Advertisement
Canada markets closed

  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,239.66
    +153.86 (+0.40%)
     

  • CAD/USD

    0.7316
    -0.0007 (-0.09%)
     

  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     

  • Bitcoin CAD

    87,549.81
    -929.53 (-1.05%)
     

  • CMC Crypto 200

    1,383.71
    -12.82 (-0.92%)
     

  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     

  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     

  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

Today's Research Reports on CRH Medical, TSO3, Emerald Health Therapeutics, and DiaMedica Therapeutics

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / August 20, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDIInitiates Coverage on:

CRH MedicalCorporation
https://rdinvesting.com/news/?ticker=CRH.TO

TSO3 Inc.
https://rdinvesting.com/news/?ticker=TOS.TO

EmeraldHealth Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=EMH.V

DiaMedicaTherapeutics Inc.
https://rdinvesting.com/news/?ticker=DMA.V

ADVERTISEMENT

CRH Medical's stock moved 4.47% higher Friday, to close the day at $5.14. The stock recorded a trading volume of 472,439 shares, which was above its three months average volume of 156,066 shares. In the last year, CRH Medical's shares have traded in a range of 1.86 - 5.23. The share price has gained 176.34% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $4.30 is greater than its 200-day moving average of $4.00. Shares of CRH Medical are trading at a Price to Earnings ratio of 59.77. Shares of CRH Medical have gained approximately 55.29 percent year-to-date.

AccessRDI's CRH Medical Corporation Research Report at:
https://rdinvesting.com/news/?ticker=CRH.TO

On Friday, shares of TSO3 recorded a trading volume of 201,287 shares, which was above the three months average volume of 114,919 shares. The stock ended the day 8.00% lower at 0.69. The share price has gained 23.21% from its 52 week low with a 52 week trading range of 0.56 - 2.87. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.82 is below its 200-day moving average of $1.00. Shares of TSO3 have fallen approximately 73.56 percent year-to-date.

AccessRDI's TSO3 Inc. Research Report at:
https://rdinvesting.com/news/?ticker=TOS.TO

Emerald Health Therapeutics' stock moved 3.23% higher Friday, to close the day at $2.88. The stock recorded a trading volume of 512,902 shares, which was below its three months average volume of 743,035 shares. In the last year, Emerald Health Therapeutics' shares have traded in a range of 1.10 - 9.68. The share price has gained 161.82% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $2.91 is below its 200-day moving average of $4.46. Shares of Emerald Health Therapeutics have fallen approximately 44.72 percent year-to-date.

AccessRDI's Emerald Health Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EMH.V

On Friday, shares of DiaMedica Therapeutics recorded a trading volume of 174,380 shares, which was below the three months average volume of 236,398 shares. The stock ended the day 2.00% lower at 0.49. The share price has gained 133.33% from its 52 week low with a 52 week trading range of 0.21 - 0.90. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.65 is greater than its 200-day moving average of $0.53. Shares of DiaMedica Therapeutics have gained approximately 68.97 percent year-to-date.

AccessRDI's DiaMedica Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=DMA.V

Our Actionable Research on CRH Medical Corporation (TSX: CRH.TO) and TSO3 Inc. (TSX: TOS.TO) and Emerald Health Therapeutics, Inc. (TSX-V: EMH.V) and DiaMedica Therapeutics Inc. (TSX-V: DMA.V) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com